Sedation for the care of patients with advanced cancer
- 1 September 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 3 (9) , 492-500
Abstract
Sedation in the context of palliative medicine is the monitored use of medications to induce varying degrees of unconsciousness to bring about a state of decreased or absent awareness (i.e. unconsciousness) in order to relieve the burden of otherwise intractable suffering. Sedation is used in palliative care in several settings: transient controlled sedation, sedation in the management of refractory symptoms at the end of life, emergency sedation, respite sedation, and sedation for refractory psychological or existential suffering. Sedation is controversial in that it diminishes the capacity of the patient to interact, function, and, in some cases, live. There is no distinct ethical problem in the use of sedation to relieve otherwise intolerable suffering in patients who are dying. Since all medical treatments involve risks and benefits, each potential option must be evaluated for its promise with regards to achieving the goals of care. When risks of treatment are involved, to be justified these risks must be proportionate to the gravity of the clinical indication. Some aspects of management, such as the need for hydration in patients undergoing sedation and the use of sedation in the management of psychological and spiritual suffering, remain controversial.Keywords
This publication has 68 references indexed in Scilit:
- Differences in physician-reported practice in palliative sedation therapySupportive Care in Cancer, 2004
- End-of-life decision-making in six European countries: descriptive studyThe Lancet, 2003
- Palliative sedation vs. terminal sedation: What’s in a name?American Journal of Hospice and Palliative Medicine®, 2002
- Temporary Sedation with Midazolam for Control of Severe Incident PainJournal of Pain and Symptom Management, 2001
- CommentaryJournal of Pain and Symptom Management, 1998
- Sedation for symptom control in Japan: The importance of intermittent use and communication with family membersJournal of Pain and Symptom Management, 1996
- The use of propofol in palliative medicineJournal of Pain and Symptom Management, 1995
- Propofol in terminal careJournal of Pain and Symptom Management, 1995
- The use of chlorpromazine for symptom control in dying cancer patientsJournal of Pain and Symptom Management, 1994
- The Nature of Suffering and the Goals of MedicineNew England Journal of Medicine, 1982